Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Childhood obesity linked to worse MS brain damage?

NCT ID NCT04593082

First seen Apr 30, 2026 · Last updated Jun 19, 2026 · Updated 9 times

Summary

This study looks at whether obesity makes multiple sclerosis (MS) worse in children. Researchers will compare brain scans and blood markers between normal-weight and overweight/obese kids recently diagnosed with MS. The goal is to understand how obesity might drive inflammation and brain volume loss, which could lead to better ways to treat MS early.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • University of Virginia

    Charlottesville, Virginia, 22903, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could reveal how obesity worsens MS in children, pointing toward new strategies to slow the disease early on.

What could go wrong

This is an observational study, not a treatment trial. It may find no clear link, and results may not apply to all children with MS.

Conditions

The condition(s) this trial relates to.

Inflammation multiple sclerosis Nerve Degeneration Obesity relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.